UBS AM
BRLI

UBS AM’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

UBS AM’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-126,973
Closed -$5.24M – 2731
2015
Q2 		$5.24M Sell
126,973
-32,367
-20% -$1.16M 0.01% 1043
2015
Q1 		$5.62M Buy
159,340
+36,500
+30% +$1.23M 0.01% 1021
2014
Q4 		$3.95M Sell
122,840
-9,098
-7% -$263K ﹤0.01% 1094
2014
Q3 		$3.7M Sell
131,938
-4,917
-4% -$150K ﹤0.01% 1100
2014
Q2 		$4.14M Sell
136,855
-4,144
-3% -$114K ﹤0.01% 1085
2014
Q1 		$3.9M Sell
140,999
-4,800
-3% -$126K ﹤0.01% 1104
2013
Q4 		$3.72M Sell
145,799
-22,089
-13% -$681K ﹤0.01% 1082
2013
Q3 		$5.02M Sell
167,888
-3,800
-2% -$106K 0.01% 984
2013
Q2 		$4.94M Buy
+171,688
New +$4.73M 0.01% 956

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

UBS AM's BRLI Position: Q3 2015 in Review

UBS AM sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 126,973 shares — an estimated $5.24M sold.

UBS AM first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $5.62M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • UBS AM reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • UBS AM sold 126,973 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $5.24M.
  • UBS AM first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • UBS AM's BIO-REFERENCE LABS INC-NEW- position peaked at $5.62M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on UBS AM's 13F filing for Q3 2015, filed 29 Oct 2015.